Armistice Capital »

Xencor shares owned by Armistice Capital

Quarter-by-quarter ownership of Xencor (XNCR) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Xencor

Tip: Access up to 7 years of quarterly data

All positions including Xencor held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xencor by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $30M 1.5M 20.15
2023-06-30 $22M 892k 24.97
2023-03-31 $23M 836k 27.89

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Xencor

PRIMECAP Management Company
Vanguard Group
EcoR1 Capital
T. Rowe Price Associates
Dimensional Fund Advisors
Candriam Luxembourg S.C.A.
Charles Schwab Investment Management
Jpmorgan Chase & Co
Bank of New York Mellon
Goldman Sachs Group
Two Sigma Investments
Millennium Management
Norges Bank Investment Management
Principal Financial Group
Two Sigma Advisers

View all funds holding Xencor